What does E.C.F. MEDICAL do?

E.C.F. MEDICAL is a specialist medical practice in Overijse. Private Limited, started on 9 November 2004, 1 establishment.

What is the address of E.C.F. MEDICAL?

The registered office of E.C.F. MEDICAL is located at Terholstdreef 34, 3090 Overijse.

Is E.C.F. MEDICAL still active?

Yes. According to the CBE (1 October 2026) E.C.F. MEDICAL is active, legal situation “Normale toestand”, started on 9 November 2004.

Is E.C.F. MEDICAL registered on Peppol?

Yes, E.C.F. MEDICAL is registered on the Peppol network with ID 0208:0869910054.

What is the enterprise number of E.C.F. MEDICAL?

The enterprise number of E.C.F. MEDICAL is BE0869910054.

When was E.C.F. MEDICAL founded?

E.C.F. MEDICAL was founded on 9 November 2004.

Who are the directors of E.C.F. MEDICAL?

According to the 2024 annual accounts, the directors of E.C.F. MEDICAL are: Caroline VAN ASSCHE.

Is E.C.F. MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 November 2004; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did E.C.F. MEDICAL make in 2024?

E.C.F. MEDICAL recorded a loss after taxes of € 12,485 in financial year 2024.

What is the revenue of E.C.F. MEDICAL?

As a small company, E.C.F. MEDICAL is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € -1,735.

E.C.F. MEDICAL (Private Limited) - Overijse

Dossier E.C.F. MEDICAL, printed on 1 October 2026 from databakkes.be/en/0869910054/e-c-f-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2023 and 2024.
Tight liquidity NBB

Cash and receivables cover 10 % of short-term debt in 2024; threshold 65 %.

Financials

Financial year 2024

E.C.F. MEDICAL from Overijse, company number BE0869910054, closed financial year 2024 with a result of € -12,485 after tax. For that financial year E.C.F. MEDICAL recorded a gross margin of € -1,735 and equity of € 11,677. Compared with financial year 2023, the result moved from € -16,002 to € -12,485. The company made a loss. The buffer shrank hard: equity is 90 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2025.

What it is worth Shrank hard

€ 11,677

▼ 90% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -12,485

▲ 22 % less loss than in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 7,172

▼ 74% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -723.

People and assets in 2024

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,774

▼ 29% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 77,135

▼ 13% vs 2023

€ 11,731 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Taxes

€ 5,096

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 54,561 Gross margin 2021: € 54,561 First fiscal year in the series	€ -15,169 Gross margin 2022: € -15,169 ▼ € 69,730 vs 2021 (€ 54,561) Unfavourable step	€ -5,638 Gross margin 2023: € -5,638 ▲ € 9,531 vs 2022 (€ -15,169) Favourable step	€ -1,735 Gross margin 2024: € -1,735 ▲ € 3,903 vs 2023 (€ -5,638) Favourable step	▲ € 3,903
Profit after taxes	€ -17,944 Profit after taxes 2021: € -17,944 First fiscal year in the series	€ -34,509 Profit after taxes 2022: € -34,509 ▼ € 16,565 vs 2021 (€ -17,944) Unfavourable step	€ -16,002 Profit after taxes 2023: € -16,002 ▲ € 18,507 vs 2022 (€ -34,509) Favourable step	€ -12,485 Profit after taxes 2024: € -12,485 ▲ € 3,517 vs 2023 (€ -16,002) Favourable step	▲ € 3,517
Equity	€ 173,174 Equity 2021: € 173,174 First fiscal year in the series	€ 138,665 Equity 2022: € 138,665 ▼ 20% vs 2021 (€ 173,174) Unfavourable step	€ 122,663 Equity 2023: € 122,663 ▼ 12% vs 2022 (€ 138,665) Unfavourable step	€ 11,677 Equity 2024: € 11,677 ▼ 90% vs 2023 (€ 122,663) Unfavourable step	▼ 90%
Total debts	€ 136,069 Total debts 2021: € 136,069 First fiscal year in the series	€ 103,438 Total debts 2022: € 103,438 ▼ 24% vs 2021 (€ 136,069) Favourable step	€ 89,406 Total debts 2023: € 89,406 ▼ 14% vs 2022 (€ 103,438) Favourable step	€ 153,476 Total debts 2024: € 153,476 ▲ 72% vs 2023 (€ 89,406) Unfavourable step	▲ 72%
Cash	€ 109,316 Cash 2021: € 109,316 First fiscal year in the series	€ 48,133 Cash 2022: € 48,133 ▼ 56% vs 2021 (€ 109,316) Unfavourable step	€ 27,591 Cash 2023: € 27,591 ▼ 43% vs 2022 (€ 48,133) Unfavourable step	€ 7,172 Cash 2024: € 7,172 ▼ 74% vs 2023 (€ 27,591) Unfavourable step	▼ 74%
Land & buildings	€ 3,240 Land & buildings 2021: € 3,240 First fiscal year in the series	€ 2,882 Land & buildings 2022: € 2,882 ▼ 11% vs 2021 (€ 3,240) Unchanged	€ 2,523 Land & buildings 2023: € 2,523 ▼ 12% vs 2022 (€ 2,882) Unchanged	€ 2,165 Land & buildings 2024: € 2,165 ▼ 14% vs 2023 (€ 2,523) Unchanged	▼ 14%
Retained profit	€ 160,774 Retained profit 2021: € 160,774 First fiscal year in the series	€ 126,265 Retained profit 2022: € 126,265 ▼ 21% vs 2021 (€ 160,774) Unfavourable step	€ 110,263 Retained profit 2023: € 110,263 ▼ 13% vs 2022 (€ 126,265) Unfavourable step	€ -723 Retained profit 2024: € -723 ▼ € 110,986 vs 2023 (€ 110,263) Unfavourable step	▼ € 110,986
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 0 Dividend 2022: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 98,500 Dividend 2024: € 98,500 Unchanged (€ 0) Unchanged
Bank debt	€ 120,512 Bank debt 2021: € 120,512 First fiscal year in the series	€ 100,111 Bank debt 2022: € 100,111 ▼ 17% vs 2021 (€ 120,512) Favourable step	€ 88,703 Bank debt 2023: € 88,703 ▼ 11% vs 2022 (€ 100,111) Favourable step	€ 77,135 Bank debt 2024: € 77,135 ▼ 13% vs 2023 (€ 88,703) Favourable step	▼ 13%
Balance sheet total	€ 309,243 Balance sheet total 2021: € 309,243 First fiscal year in the series	€ 242,103 Balance sheet total 2022: € 242,103 ▼ 22% vs 2021 (€ 309,243) Unchanged	€ 212,069 Balance sheet total 2023: € 212,069 ▼ 12% vs 2022 (€ 242,103) Unchanged	€ 165,153 Balance sheet total 2024: € 165,153 ▼ 22% vs 2023 (€ 212,069) Unchanged	▼ 22%

Key figures of E.C.F. MEDICAL, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to E.C.F. MEDICAL?

What happened at E.C.F. MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 26, 2025 New annual accounts for financial year 2024: loss of € 12,485. filed late Source: NBB ↗
Nov 9, 2004 New establishment in Rixensart. KBO
Nov 9, 2004 Start of the company according to the CBE. KBO

In short

From € 17,944 loss in 2021 to € 12,485 loss in 2024.

Paid € 3,222 in corporate taxes since 2021.

Paid out € 98,500 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at E.C.F. MEDICAL? We notify you, reason included.

Follow E.C.F. MEDICAL

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Caroline VAN ASSCHE

E.C.F. MEDICAL

Behind E.C.F. MEDICAL is Caroline VAN ASSCHE.

See the full network in the app

Directors

According to the 2024 annual accounts

Caroline VAN ASSCHE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Terholstdreef 34

3090 Overijse

2.216.856.014

Chemin du Meunier 9

1330 Rixensart

Active since 9 November 2004

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0869.910.054
VAT number: BE 0869.910.054
Registered office: Terholstdreef 34, 3090 Overijse
Names & denominations: E.C.F. MEDICAL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 9 November 2004
Peppol: Active · Active since 9 Jun 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗